Navigation Links
Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
Date:2/29/2008

16 29

Deferred revenue 228 228

Accrued severance pay 324 344

Total Long-term Liabilities 568 601

COMMITMENTS AND CONTINGENT LIABILITIES

SHAREHOLDERS' EQUITY:

Share capital: 27 17

Additional paid-in capital 58,984 31,958

Other comprehensive income 86 3

Deferred stock-based compensation - (48)

Deficit accumulated during the

development stage (35,492) (20,831)

Total shareholders' equity 23,605 11,099

Total liabilities and shareholders'

equity 26,038 $ 13,243

[1] Avastin is a registered trademark of Genentech, Inc.

Contact: Media

Rachel Spielman

T: +1-212-583-2714

E: media@rosettagenomics.com

Investors

Ron Kamienchick

T: +1-646-509-1893

E: investors@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Rosetta Genomics Establishes Medical Advisory Board
2. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
3. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
4. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
5. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
6. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
7. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
8. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
11. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2010)... March 11, 2010 , ProFibrix B.V., a leader in the development of ... II trial testing its unique new hemostat,Fibrocaps(TM). Promising preliminary data from the European ... good performance of the delivery device. , ... ... ...
(Date:3/10/2010)... March 10, 2010 Complete Genomics Inc., ... that the Institute for Systems Biology (ISB) employed ... a family quartet to determine the depth of ... sequence, and to verify the gene responsible for ... collaboration will be published online later today in ...
(Date:3/10/2010)... ... ... ... , ... , , ...
(Date:3/10/2010)... Photometrics releases its exclusive PVCAM universal programming interface, which supports ... Vista 64. , ... (PRWEB) March ... CCD and EMCCD cameras for the life sciences, has announced ... universal programming interface. This new driver adds support for Microsoft’s ...
Breaking Biology Technology:ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 2ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 3Institute for Systems Biology uses Complete Genomics' genome sequencing service to verify gene responsible for Miller syndrome 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 3Photometrics Introduces 64-Bit PVCAM Driver 2
... Institute of Standards and Technology (NIST) have developed ... of magnetic materials such as nickel or nickel-iron ... The process, described in a recent paper,* could ... (MEMS) devices. , The NIST team also demonstrated ...
... 26 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc.,("Dragon Pharma" or ... a,leading international pharmaceutical company, today announced the results,of ... 2008 in Shenzhen,China., There were 48,663,865 shares ... meeting. The shareholders re-elected the following,eight persons to ...
... 26 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... has,ruled in favor of its subsidiary, Barr Laboratories, ... Boehringer Ingelheim Pharmaceuticals, Inc. in,connection with Boehringer Ingelheim,s ... 1.5mg., In his ruling, District Court Judge ...
Other Biology Technology:New process creates 3-D nanostructures with magnetic materials 2Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 2Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 3Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 4
(Date:3/11/2010)... better manage their disease by controlling their food intake ... of needing treatment that makes them hungry, researchers said. ... prevent weight gain may suggest an eating disorder when ... Dr. Deborah Young-Hyman, pediatric psychologist at the Medical College ... use the same criteria to diagnose eating disorders that ...
(Date:3/11/2010)... PHILADELPHIA - Millions of people in both the ... immune-system research findings from the University of Pennsylvania ... researchers, studying how the immune system operates, have ... be the body,s double-edged sword, fighting off parasitic ... that can lead to allergies and asthma. , ...
(Date:3/11/2010)... Wisconsin-Madison have designed a way to harvest small amounts ... into usable hydrogen fuel. , The process is simple, ... , "This study provides a simple and cost-effective technology ... by scavenging energy wastes such as noise or stray ... new paper, published March 2 in the Journal ...
Breaking Biology News(10 mins):Diabetes' link to eating disorders explored 2Diabetes' link to eating disorders explored 3Penn researchers identify immune cells that fight parasites may promote allergies and asthma 2Scavenging energy waste to turn water into hydrogen fuel 22009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women 26apos 3Bs Health of North America in Florida 62229 12009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women 26apos 3Bs Health of North America in Florida 62229 22009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women 26apos 3Bs Health of North America in Florida 62229 3Raphaelson 26amp 3B Levine Secures 241 1 Million Verdict for Victim of New York Construction Accident 62226 1Raphaelson 26amp 3B Levine Secures 241 1 Million Verdict for Victim of New York Construction Accident 62226 2Beverage Can Stay Tabs Pose Swallowing Risk 62223 1Beverage Can Stay Tabs Pose Swallowing Risk 62223 2
... to the new study, the presence of caspase-12, which ... increases the body's "vulnerability to bacterial infection and septic ... This new discovery suggests that caspase-12 antagonists could be ... other inflammatory and immune disorders. , The study ...
... gelling agent in making jams and jellies, but its ... and may have a role in important biological functions ... , Despite the importance of pectin as a major ... known relatively little about how this family of complex ...
... among the most complex in the animal kingdom. Researchers have ... uses sound units to build phrases that can be combined ... only humans have demonstrated the ability to use such a ... March 2006 issue of the Journal of the Acoustical Society ...
Other Biology News:Lack of a key enzyme dramatically increases resistance to sepsis 2Lack of a key enzyme dramatically increases resistance to sepsis 3Discovery of new molecular tools for biosynthesis could lead to advances in use of pectin 2Discovery of new molecular tools for biosynthesis could lead to advances in use of pectin 3Warbling whales speak a language all their own 2Warbling whales speak a language all their own 3
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
...
Biology Products: